Patent · US Active

Growth factor isoform

US8933211B2 · kind B2 · utility

0Cited by

3References

15Claims

0Family size

Assignee

The University of Bristol · GB

Inventors

David Bates · Bristol, GB
Steven Harper · Roma, IT

Key dates

Filing date	Feb 1, 2013
Grant date	Jan 13, 2015
Priority date	—
Expiry date	Feb 1, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/71
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An isolated VEGF polypeptide having anti-angiogenic activity, said polypeptide including the amino acid sequence of SEQ. ID NO. 1, or variants thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.